COX-2, a prostaglandin-endoperoxide synthase 2 enzyme, generates prostanoids such as prostaglandin E2, which modulate carcinogenic effects.27 It is commonly expressed in different types of cancer and plays multifaceted roles in carcinogenesis and treatment resistance. The gene discussed is PTGS2; the disease is cancer.